Jeffrey Cummings, M.D., Sc.D.

University of Nevada Las Vegas

Contact Information

Jeffrey Cummings, M.D., Sc.D.
Las Vegas, United States

Professional Information

Chair, Chambers-Grundy Center for Transformative Neuroscience
University of Nevada Las Vegas

Education

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:
[Last updated: Nov 10, 2020]

Dr. Cummings has provided consultation to Acadia, Actinogen, Acumen, Alector, Alkahest, Alzheon, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Cassava, Cerecin, Cerevel, Cortexyme, Cytox, EIP Pharma, Eisai, Foresight, GemVax, Genentech, Green Valley, Grifols, Janssen, Karuna, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Samumed, Samus, Signant Health, Sunovion, Suven, and United Neuroscience pharmaceutical and assessment companies. Dr. Cummings has stock options in ADAMAS, AnnovisBio, MedAvante, BiOasis. Dr. Cummings owns the copyright of the Neuropsychiatric Inventory. Dr Cummings is supported by NIGMS grant P20GM109025; NINDS grant U01NS093334; NIA grant R01AG053798; and NIA grant P20AG068053.